Benchmarking homologous recombination deficiency algorithms for prediction of clinical outcome in ovarian cancer
Lasse Ringsted Mark, Inge Søkilde Pedersen, Anne Krejbjerg, Henrik Bygum Krarup, Karen Dybkær, Ida Burchardt Egendal, Helle Damgaard Zacho, Mads Thomassen, Martin Bøgsted
This study benchmarks three HRD detection algorithms in ovarian cancer patients, finding all showed significant association with improved progression-free survival, while BRCA1/2 mutations did not.
medRxiv · Oct 8, 2025 · PreprintGenetic & Genomic Medicine